Tenet Healthcare (NYSE:THC) Releases FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 16.190-18.470 for the period, compared to the consensus estimate of 16.540. The company issued revenue guidance of $21.5 billion-$22.3 billion, compared to the consensus revenue estimate of $21.8 billion.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday. Mizuho upped their target price on shares of Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a research report on Friday, October 17th. Cantor Fitzgerald upped their price target on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Finally, UBS Group set a $288.00 target price on Tenet Healthcare and gave the company a “buy” rating in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $239.50.

Tenet Healthcare Trading Up 4.1%

Shares of NYSE:THC traded up $9.24 during midday trading on Thursday, reaching $235.59. The company had a trading volume of 1,001,598 shares, compared to its average volume of 1,022,786. The company has a fifty day simple moving average of $198.00 and a two-hundred day simple moving average of $193.90. The company has a debt-to-equity ratio of 2.27, a quick ratio of 1.64 and a current ratio of 1.71. The firm has a market cap of $20.70 billion, a price-to-earnings ratio of 16.15, a price-to-earnings-growth ratio of 0.82 and a beta of 1.44. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $235.77.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the prior year, the firm earned $3.44 earnings per share. The business’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts predict that Tenet Healthcare will post 12.24 earnings per share for the current year.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.81% of the stock is owned by insiders.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 beat: Tenet reported EPS of $4.70 (vs. ~$4.08 est.) and revenue of $5.53B (+8.9% YoY), driven by hospital and ambulatory surgery growth — the core driver of today’s bullish move. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Raised/solid 2026 outlook: Tenet provided FY-2026 EPS guidance (16.190–18.470) and an adjusted EBITDA target ($4.485B–$4.785B), signaling continued margin focus, cost initiatives and M&A optionality. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target amid structural cost initiatives and M&A focus
• Positive Sentiment: Market reaction: Coverage notes the post-earnings rally and a new 1‑year / record-high trading level as investors reward the beat and outlook. Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings
• Neutral Sentiment: Call materials and transcripts available — management discussed demand dynamics, capital allocation and cost programs; useful for parsing sustainability of results and guidance. Tenet Healthcare Corporation (NYSE: THC) Q4 2025 earnings call transcript
• Neutral Sentiment: Coverage summaries emphasize strong surgery and hospital volume as the near-term revenue driver; slide deck and press release give more detail on segment performance. Tenet Healthcare Profit Rises on Ambulatory and Hospital Revenue Growth
• Negative Sentiment: Policy headwind: Tenet expects roughly a $250M hit this year from the loss of ACA premium subsidies, which will pressure earnings and cash flow if not offset by volume or cost actions. Tenet expects $250M hit from loss of ACA subsidies this year
• Negative Sentiment: Margin caution: Some analysts flag that 2026 guidance could imply a lower EBITDA margin despite higher revenue — a potential source of downside to model-driven valuations if cost saves fall short. Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Qtron Investments LLC raised its position in shares of Tenet Healthcare by 202.2% in the fourth quarter. Qtron Investments LLC now owns 3,076 shares of the company’s stock valued at $611,000 after purchasing an additional 2,058 shares during the period. Nuveen LLC lifted its position in Tenet Healthcare by 12.0% during the 4th quarter. Nuveen LLC now owns 1,155,677 shares of the company’s stock worth $229,656,000 after acquiring an additional 124,223 shares during the last quarter. MIdWestOne Financial Group Inc. grew its position in shares of Tenet Healthcare by 35.4% in the fourth quarter. MIdWestOne Financial Group Inc. now owns 5,676 shares of the company’s stock valued at $1,128,000 after purchasing an additional 1,483 shares during the last quarter. Picton Mahoney Asset Management lifted its position in shares of Tenet Healthcare by 144.4% during the 4th quarter. Picton Mahoney Asset Management now owns 3,121 shares of the company’s stock worth $620,000 after purchasing an additional 1,844 shares during the last quarter. Finally, Meeder Asset Management Inc. grew its holdings in Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.